Tag: Biotechnology Research

United States

bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise research and opens new doors for developing effective treatments. CAMBRIDGE, England – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announces the launch … Continue reading bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain

Impact Newswire
Bio-Rad
United States

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

HERCULES, Calif – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024. “We are very pleased to welcome Anette Engelhardt as President of our Clinical Diagnostics Group”Post this Ms. Engelhardt … Continue reading Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Impact Newswire
Biocom California
United States

Tim Scott to Succeed Joe Panetta as Biocom California President and CEO

Panetta to transition to President Emeritus SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO – Biocom California, the association representing the California life science industry, today announced that it has named Tim Scott as its president and CEO, effective January 1, 2025. Mr. Scott will succeed Joe Panetta, Biocom California’s current president and CEO, who has led the organization for 25 years. Mr. … Continue reading Tim Scott to Succeed Joe Panetta as Biocom California President and CEO

Impact Newswire
Vivodyne
United States

Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

PHILADELPHIA – Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development, today announced the appointment of Julie O’Shaughnessy as Chief Operating Officer. In her new role, Julie will oversee business operations, strategic planning, finance, people operations, and multisite expansion, driving the company’s operational excellence and strategic growth initiatives. “Julie has been instrumental in Vivodyne’s growth … Continue reading Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

Impact Newswire
Bruker
United States

Bruker Completes Asset Acquisition of NanoString Business

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis. “We have a proven track record in successfully integrating and nurturing … Continue reading Bruker Completes Asset Acquisition of NanoString Business

Impact Newswire
Agilent Technologies
United States

Padraig McDonnell Assumes Agilent CEO Role

SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. 31. “It’s an incredible honor to serve as CEO … Continue reading Padraig McDonnell Assumes Agilent CEO Role

Impact Newswire
Generate:Biomedicines
United States

Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

SOMERVILLE, Mass. – Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only enhance the company’s leadership team, but also reflect its commitment to gender diversity, with over half of the leadership team represented by women. White’s arrival and Wyman’s promotion are … Continue reading Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Impact Newswire
KBI Biopharma
United States

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

DURHAM, N.C.–(BUSINESS WIRE)–KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team. “JB’s appointment underscores this dedication, perfectly aligning with our team’s mission to deliver innovative, top-tier solutions tailored to our customers’ evolving needs. His servant leadership philosophy will further fortify … Continue reading KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Impact Newswire